Literature DB >> 15549607

The Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities.

B Gebert1, W Fischer, R Haas.   

Abstract

Helicobacter pylori is a highly successful bacterial pathogen of humans, infecting the stomach of more than half of the world's population. The H. pylori infection results in chronic gastritis, eventually followed by peptic ulceration and, more rarely, gastric cancer. H. pylori has developed a unique set of virulence factors, actively supporting its survival in the special ecological niche of the human stomach. Vacuolating cytotoxin (VacA) and cytotoxin-associated antigen A (CagA) are two major bacterial virulence factors involved in host cell modulation. VacA, so far mainly regarded as a cytotoxin of the gastric epithelial cell layer, now turns out to be a potent immunomodulatory toxin, targeting the adapted immune system. Thus, in addition to the well-known vacuolating activity, VacA has been reported to induce apoptosis in epithelial cells, to affect B lymphocyte antigen presentation, to inhibit the activation and proliferation of T lymphocytes, and to modulate the T cell-mediated cytokine response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15549607     DOI: 10.1007/s10254-004-0027-3

Source DB:  PubMed          Journal:  Rev Physiol Biochem Pharmacol        ISSN: 0303-4240            Impact factor:   5.545


  16 in total

1.  Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA.

Authors:  Kelly A Gangwer; Carrie L Shaffer; Sebastian Suerbaum; D Borden Lacy; Timothy L Cover; Seth R Bordenstein
Journal:  J Bacteriol       Date:  2010-09-24       Impact factor: 3.490

2.  Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China.

Authors:  Xiangting Zeng; Yumin Li; Tao Liu; Junqiang Zhang
Journal:  Mol Cell Biochem       Date:  2011-11-13       Impact factor: 3.396

3.  Lymphocyte proliferative response to Helicobacter pylori antigens in H. pylori-infected patients.

Authors:  M Hybenova; P Hrda; B Potuznikova; E Pavlik; V Stejskal; J Dosedel; I Sterzl
Journal:  Folia Microbiol (Praha)       Date:  2011-01-21       Impact factor: 2.099

4.  Helicobacter pylori VacA toxin promotes bacterial intracellular survival in gastric epithelial cells.

Authors:  M R Terebiznik; C L Vazquez; K Torbicki; D Banks; T Wang; W Hong; S R Blanke; M I Colombo; N L Jones
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

Review 5.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

6.  Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner.

Authors:  Luisa F Jiménez-Soto; Stefan Kutter; Xaver Sewald; Claudia Ertl; Evelyn Weiss; Ulrike Kapp; Manfred Rohde; Torsten Pirch; Kirsten Jung; S Francesco Retta; Laurent Terradot; Wolfgang Fischer; Rainer Haas
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

7.  Analysis of a beta-helical region in the p55 domain of Helicobacter pylori vacuolating toxin.

Authors:  Susan E Ivie; Mark S McClain; Holly M Scott Algood; D Borden Lacy; Timothy L Cover
Journal:  BMC Microbiol       Date:  2010-02-23       Impact factor: 3.605

Review 8.  Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature.

Authors:  Jay Luther; Maneesh Dave; Peter D R Higgins; John Y Kao
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

9.  Prevalence of vacA, cagA and babA2 genes in Cuban Helicobacter pylori isolates.

Authors:  Lino E Torres; Karelia Melián; Arlenis Moreno; Jordis Alonso; Carlos A Sabatier; Mayrín Hernández; Ludisleydis Bermúdez; Boris L Rodríguez
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

10.  The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis.

Authors:  T Rokkas; J P Gisbert; Y Niv; C O'Morain
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.